GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » Valuation Rank

Clearbridge Health (SGX:1H3) Valuation Rank


View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Clearbridge Health Valuation Rank Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearbridge Health (SGX:1H3) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » Valuation Rank
Comparable Companies
SGX:505 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN LH DGX WAT XPAR:BIM EXAS RVTY XPAR:ERF ASX:SHL CRL
Traded in Other Exchanges
N/A
Address
37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177
Website
https://www.clearbridgehealth.com
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.